Moderna Inc.

History

Year	Detail
2010	The company has established in 2010 and the name Moderna combines the words "modified" and "RNA", which happens to contain the word "modern."
2011	Moderna begins research into the production of mRNA medicines, and Stephane Bancel joins as founding CEO.
2014	Moderana's new headquarters and labs open in Cambridge, Massachusetts.
2015	Moderna initiates the first-in-human dose of an mRNA vaccine (mRNA-1440), an H10N8 flu vaccine candidate.
2016	It has opened a GMP mRNA clinical manufacturing facility in Norwood, Massachusetts, in the U.S.
2017	Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease.
2018	The company has opened its state-of-the-art clinical development site in Norwood, Massachusetts, in the U.S.
2019	It has announced the dosing of the first antibody encoded by mRNA in a clinical trial.
2022	Biologics License Application (BLA) received the approval of The U.S. Food and Drug Administration for SPIKEVAX.
2024	Moderna and OpenAI Collaborate To Advance mRNA Medicine. Moderna's Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada and it also received European Commission Approval for RSV Vaccine mRESVIA.